logo

For the Inventor, By the Inventor

Seoul, South Korea

Toolgen Inc.

Calculating rank
USPTO Granted Patents = 23

% Expired Patents = 4.3



Trademarks = 1

Forward Citations = 59

Loading Chart...
Loading Chart...

45 inventors (with patents filed for the assignee):

goldMedal Dong Woo Song (8 out of 9 patents)

silverMedal Seok Joong Kim (7 out of 29 patents)

bronzeMedal Seokjoong Kim (7 out of 9 patents)

4.  Jung Min Lee (6 out of 62 patents)

5.  Min Hee Jung (6 out of 6 patents)

6.  Jae Young Lee (4 out of 57 patents)

7.  Jin-Soo Kim (3 out of 150 patents)

8.  Hee Sook Bae (3 out of 3 patents)

9.  Kyu Jun Lee (3 out of 3 patents)

10.  Yoon-young Kim (2 out of 6 patents)

11.  Sojung Kim (2 out of 5 patents)

12.  Joonsun Lee (2 out of 2 patents)

13.  Eunji Shin (2 out of 2 patents)

14.  Jeongjoon Lee (2 out of 2 patents)

15.  Gyu-bon Cho (2 out of 2 patents)


23 patents:

1. 12674150 - TARGET-SPECIFIC CRISPR MUTANT (2026-07-07),
2. 12644107 - TARGET-SPECIFIC CRISPR MUTANT (2026-06-02),
3. 12642256 - HEMOPHILIA B RAT MODEL (2026-06-02),
4. 12509697 - OLEIC ACID -ENRICHED PLANT BODY HAVING GENETICALLY MODIFIED FAD2 AND PRODUCTION METHOD THEREOF (2025-12-30),
5. 12486521 - PLATFORM FOR EXPRESSING PROTEIN OF INTEREST IN LIVER (2025-12-02),
6. 12473559 - Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells (2025-11-18),
7. 12351838 - Target-specific CRISPR mutant (2025-07-08),
8. 12331086 - Artificially engineered SC function control system (2025-06-17),
9. 12286635 - Oleic acid-enriched plant body having genetically modified FAD2 and production method thereof (2025-04-29),
10. 12275963 - Artificially manipulated immune cell (2025-04-14),
11. 12241071 - Composition for editing flavonoid biosynthetic gene by using CRISPR/Cas9 system, and use thereof (2025-03-04),
12. 12163149 - Artificial genome manipulation for gene expression regulation (2024-12-10),
13. 12012598 - Manipulated immunoregulatory element and immunity altered thereby (2024-06-18),
14. 11999952 - Artificially-manipulated neovascularization regulatory system (2024-06-04),
15. 11920151 - Method for identifying DNA base editing by means of cytosine deaminase (2024-03-05),
Company Overview
Toolgen Inc. is a biotechnology company based in Seoul, South Korea, specializing in gene editing technologies. The organization focuses on developing innovative solutions for various applications, including agriculture, healthcare, and industrial biotechnology. Toolgen's expertise lies in harnessing advanced genetic engineering techniques to create precise modifications in DNA, enabling improvements in crop resilience and potential therapeutic advancements. The company is committed to advancing the field of biotechnology through research and development, aiming to address global challenges.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

23 Patents

#207 in Seoul

#574 in South Korea

#27,736 in the World

Seoul, KR
Seoul, South Korea

Toolgen Inc.

Forward Citations = 59

45 inventors:

goldMedal Dong Woo Song (8 out of 9 patents)

silverMedal Seok Joong Kim (7 out of 29 patents)

bronzeMedal Seokjoong Kim (7 out of 9 patents)

4.  Jung Min Lee (6 out of 62 patents)

5.  Min Hee Jung (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Toolgen Inc.. Retrieved from https://idiyas.com/company/toolgen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…